Keywords: fda, delays, decison, forest/cypress, milnacipran, forest, laboratories

FDA delays decison on Forest/Cypress' milnacipran

Article | 27 October 2008

Print This

Forest Laboratories and fellow USA-based Cypress Bioscience have been told by US Food and Drug Administration that it will not ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in